CoMFA/CoMSIA and Molecular Docking Studies of Novel Matrix Metalloproteinase- 2 Inhibitors Based on L-tyrosine Scaffold

Publisher： Bentham Science Publishers

E-ISSN： 1875-628x|13|5|376-386

ISSN： 1570-1808

Source： Letters in Drug Design & Discovery, Vol.13, Iss.5, 2016-06, pp. : 376-386

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

3D QSAR Pharmacophore, CoMFA and CoMSIA Based Design and Docking Studies on Phenyl Alkyl Ketones as Inhibitors of Phosphodiesterase 4

By  

Medicinal Chemistry, Vol. 8, Iss. 5, 2012-09 ,pp. : 894-912

Bentham Science Publishers

Access to resources Recommend Favorite

CoMFA, CoMSIA and HQSAR Studies of Acetylcholinesterase Inhibitors

By  

Current Computer - Aided Drug Design, Vol. 9, Iss. 3, 2013-01 ,pp. : 385-395

Bentham Science Publishers

Access to resources Recommend Favorite

CoMFA and CoMSIA Studies on Aryl Carboxylic Acid Amide Derivatives as Dihydroorotate Dehydrogenase (DHODH) Inhibitors

By  

Current Computer - Aided Drug Design, Vol. 8, Iss. 4, 2012-10 ,pp. : 271-282

Bentham Science Publishers

Access to resources Recommend Favorite

QSAR Studies on HSV-1 Inhibitors by CoMFA, CoMSIA and HQSAR Approaches

By  

Letters in Drug Design & Discovery, Vol. 7, Iss. 5, 2010-06 ,pp. : 332-340

Bentham Science Publishers

Access to resources Recommend Favorite

QSAR, Docking, and CoMFA Studies of GSK3 Inhibitors

By  

Current Pharmaceutical Design, Vol. 16, Iss. 24, 2010-08 ,pp. : 2666-2675

Bentham Science Publishers

Access to resources Recommend Favorite